Effect of a specific iron chelating agent on animal models of inflammation
about
Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cellsInhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cellsAdministration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in miceInhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in miceOxygen toxicity, oxygen radicals, transition metals and diseaseApproaches and strategies for the treatment of influenza virus infections.Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice.Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron.Modification of rheumatic symptoms by diet and drugs.Iron-chelating therapy.Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice.Is chronic synovitis an example of reperfusion injury?Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides.Effect of iron chelation on inflammatory joint disease.Pathology of warm ischaemia and reperfusion injury in adipomusculocutaneous flaps.Effect of nutritional iron deficiency on acute and chronic inflammationInvestigation of the anti-inflammatory properties of hydroxypyridinones.Antigen induced arthritis in beige (Chediak-Higashi) mice.Correlation of iron exchange between the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one(L1) and transferrin and possible antianaemic effects of L1 in rheumatoid arthritis.Effect of intravenous iron-dextran (Imferon) infusion on antigen induced monarticular arthritis in rabbits.Deferoxamine (Desferal)-induced ocular toxicity.Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy.Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): evidence for DFO as an extracellular inducer of oxidant stress in RBC.The relationship between ferritin and urate levels and risk of gout
P2860
Q24793830-57CBBCDE-F8A3-4E3F-A33B-762244F053D0Q28137812-D60B244B-DDCC-4758-ACF8-8995DDD1069BQ28366777-D4F5E367-063E-4A0B-BC38-606115470AEEQ28379301-085E262D-79C1-4EB4-902B-6E1CE2C329AAQ29615096-5AD36222-2E17-48FF-86A2-3D21AE664AF8Q33730165-E54D3886-BBC9-4587-817F-068D9773AC7BQ33799415-1A7A0DB8-89E3-4391-A1CC-460A034C2D77Q34263355-9594536D-C61B-4CDD-ABF2-A1D59B99D4DAQ38760302-EF6E2C0C-CBBB-4CAE-89B5-8B8993230A33Q39581560-E513E56B-593A-4293-AD19-7952EE035B47Q40346625-85A0BEFA-E8FD-4ABB-91E5-45F4A75498F5Q40919247-8EE1EEC1-DC27-4D07-B48C-93F72CAD7F05Q41154701-D68A3D4A-B063-4B41-B1F1-A1F34FF38CD3Q41156407-9B013EFC-66E5-42B5-BC3F-2C34997E0A44Q41159814-568CD0B1-9B26-4130-BC2E-ACB02476C5DAQ41162637-89DF8158-D768-44D9-A0A1-A14F0A782C98Q41198539-201BB9B9-4BA1-496D-8A14-486AB0CB44EFQ41207669-C86C6743-6059-41F2-928F-1581C04CC102Q41226031-093685D9-3422-45D2-AD5E-B7E3DC19E230Q41229868-6CB404AE-F6E5-4B30-8822-15C2736DBDB7Q41541697-25B856E6-A7AB-48C5-92EE-B487DACF2145Q42209452-E34227C3-D851-45E2-84AB-92423A88E3F1Q42857728-8AFDD8BD-369E-44B7-A6A5-96895D907FBCQ45129376-81D18E1D-1F7F-431A-A124-49DB1788CB5BQ45200520-00AFDE5F-8964-4D89-BDCE-8E5C2C20A25AQ45401972-FB0D9135-9AD8-461A-AFE4-58724D306AA5Q46017499-D584D1E6-FAF8-40EC-86EE-C7B6581CE8A6Q57154608-75487385-46D3-484B-A260-BF76AF930D15
P2860
Effect of a specific iron chelating agent on animal models of inflammation
description
1983 nî lūn-bûn
@nan
1983 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Effect of a specific iron chelating agent on animal models of inflammation
@ast
Effect of a specific iron chelating agent on animal models of inflammation
@en
Effect of a specific iron chelating agent on animal models of inflammation
@nl
type
label
Effect of a specific iron chelating agent on animal models of inflammation
@ast
Effect of a specific iron chelating agent on animal models of inflammation
@en
Effect of a specific iron chelating agent on animal models of inflammation
@nl
prefLabel
Effect of a specific iron chelating agent on animal models of inflammation
@ast
Effect of a specific iron chelating agent on animal models of inflammation
@en
Effect of a specific iron chelating agent on animal models of inflammation
@nl
P2093
P2860
P356
P1476
Effect of a specific iron chelating agent on animal models of inflammation
@en
P2093
B Halliwell
J M Gutteridge
P A Dieppe
P2860
P356
10.1136/ARD.42.1.89
P407
P577
1983-02-01T00:00:00Z